BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.58B |
| 2 |
Microsoft
MSFT
|
+$3.36B |
| 3 |
GE Vernova
GEV
|
+$2.86B |
| 4 |
CRH
CRH
|
+$2.57B |
| 5 |
Amazon
AMZN
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.23B |
| 2 |
GE Aerospace
GE
|
+$1.37B |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$1.23B |
| 4 |
Super Micro Computer
SMCI
|
+$1.17B |
| 5 |
AbbVie
ABBV
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.27% |
| 2 | Healthcare | 12.09% |
| 3 | Financials | 11.69% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Adtran
ADTN
$616M
| $34.7M | ﹤0.01% |
6,603,046
-5,906,703
| -47% | -$30.1M |
|
2627
Health Catalyst
HCAT
$128M
| $34.7M | ﹤0.01% |
5,432,709
+68,224
| +1% | +$438K |
|
|
KALV
2628
DELISTED
KalVista Pharmaceuticals
KALV
| $34.7M | ﹤0.01% |
2,945,116
+512,882
| +21% | +$5.99M |
|
2629
Global Industrial
GIC
$1.49B
| $34.7M | ﹤0.01% |
1,106,011
+63,240
| +6% | +$2.32M |
|
|
NXDR
2630
Nextdoor Holdings
NXDR
$986M
| $34.6M | ﹤0.01% |
12,463,553
+2,091,022
| +20% | +$4.83M |
|
|
PTVE
2631
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $34.6M | ﹤0.01% |
3,059,616
+52,406
| +2% | +$697K |
|
2632
iShares Intermediate Government/Credit Bond ETF
GVI
$3.78B
| $34.6M | ﹤0.01% |
333,475
+58,819
| +21% | +$6.06M |
|
|
CTO
2633
CTO Realty Growth
CTO
$815M
| $34.5M | ﹤0.01% |
1,973,858
+141,114
| +8% | +$2.44M |
|
2634
Symbotic
SYM
$5.22B
| $34.5M | ﹤0.01% |
980,080
+266,562
| +37% | +$10.8M |
|
2635
Corbus Pharmaceuticals
CRBP
$188M
| $34.5M | ﹤0.01% |
761,367
+540,505
| +245% | +$22.7M |
|
|
INST
2636
DELISTED
Instructure Holdings, Inc.
INST
| $34.5M | ﹤0.01% |
1,471,597
+166,623
| +13% | +$3.55M |
|
2637
Liberty Live Group Series A
LLYVA
$9.09B
| $34.4M | ﹤0.01% |
917,904
-27,727
| -3% | -$1.04M |
|
2638
Columbia Financial
CLBK
$1.13B
| $34.4M | ﹤0.01% |
2,296,024
+9,034
| +0.4% | +$140K |
|
2639
Blend Labs
BLND
$395M
| $34.3M | ﹤0.01% |
14,528,485
+12,191,787
| +522% | +$32.3M |
|
2640
Humacyte
HUMA
$194M
| $34.3M | ﹤0.01% |
7,140,014
+2,351,274
| +49% | +$12.2M |
|
2641
Allient
ALNT
$1.92B
| $34.2M | ﹤0.01% |
1,354,335
+244,444
| +22% | +$7.01M |
|
2642
Tango Therapeutics
TNGX
$4.41B
| $34.2M | ﹤0.01% |
3,987,852
+126,490
| +3% | +$977K |
|
2643
AB InBev
BUD
$165B
| $34.2M | ﹤0.01% |
588,393
+13,451
| +2% | +$824K |
|
2644
Oric Pharmaceuticals
ORIC
$1.4B
| $34.2M | ﹤0.01% |
4,830,880
+1,652,695
| +52% | +$14.8M |
|
2645
Acco Brands
ACCO
$407M
| $34.1M | ﹤0.01% |
7,247,343
-59,192
| -0.8% | -$295K |
|
2646
Resources Connection
RGP
$145M
| $34M | ﹤0.01% |
3,081,866
-2,120,157
| -41% | -$23.8M |
|
2647
Equinor
EQNR
$92.4B
| $34M | ﹤0.01% |
1,189,731
-11,994
| -1% | -$335K |
|
2648
Fomento Económico Mexicano
FMX
$41.7B
| $33.9M | ﹤0.01% |
314,601
-126,267
| -29% | -$14.8M |
|
2649
Agnico Eagle Mines
AEM
$90.5B
| $33.8M | ﹤0.01% |
516,337
-7,374
| -1% | -$481K |
|
2650
South Plains Financial
SPFI
$841M
| $33.7M | ﹤0.01% |
1,249,049
+41,404
| +3% | +$1.09M |
|
Similar funds
BlackRock's Q2 2024 Portfolio in Review
As of Q2 2024, BlackRock held 5,453 positions worth $4.42T, up 2.9% from $4.3T the previous quarter. Its ten largest holdings account for 27% of the portfolio.
BlackRock's Q2 2024 filing shows 174 new, 2,440 increased, 2,110 reduced and 172 closed positions. Its largest new stake was Solventum: 11,038,924 shares worth $584M. The largest sale was Pioneer Natural Resource Co., an estimated $4.23B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2024 buy was Solventum: 11,038,924 shares worth $584M.
- BlackRock added most to ExxonMobil in Q2 2024, an estimated $3.58B increase.
- BlackRock's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $1.37B.
- BlackRock fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.23B.
- BlackRock's ten largest holdings make up 27% of its $4.42T portfolio in Q2 2024.
- BlackRock opened 174 new positions and closed 172 in Q2 2024.
- BlackRock's portfolio value rose 2.9% quarter-over-quarter to $4.42T.
Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.